-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
Buy Canopy Growth Stock as Cannabis Again Enters the Spotlight
Canopy Growth stock has been trading better lately, giving investors a glimpse of what CGC stock can do if it regains momentum.
Canopy Growth Has a Catalyst That Few Are Talking About
The devastation from the coronavirus spared very few sectors and marijuana wasn’t one of them. However, this has created a long-term catalyst for CGC stock that few are talking about.
Catalysts Remain in Play, but Canopy Growth Stock Remains a Hold for Now
Potential needle-movers remain in motion for CGC stock. But as shares may not reflect continued challenges, hold off buying for now.
Only a Miracle Can Save Tilray Stock Now
TLRY stock is down over 97% in under two years, and there's no stopping the free fall as the company struggles on multiple fronts.
Approach Volatile Cannabis Producer Tilray Stock With Caution
Tilray has promise but near-term volatility should make investors cautious about TLRY stock.
Buy the Post-Earnings Dip in Canopy Growth Stock Now
Canopy Growth's fourth-quarter earnings report was not good. But the big-picture trends remain favorable, and CGC stock will bounce back.
Canopy Growth Stock Is Still Among the Most Compelling Marijuana Plays
CGC stock is well-positioned to become a leader in the cannabis industry with its steady partnership with a beverage industry giant.
Tilray Stock Is a Loser in the Cannabis World
Compared to its innovative peers like Cronos and Canopy Growth, Tilray is destined to fail. That's why investors should avoid TLRY stock now.
Constellation Brands Must Exercise Warrants to Keep Canopy Growth Alive
Canadian Canopy Growth is burning through cash way too quickly. That's why CGC stock is relying on Constellation Brands for survival.
3 Numbers to Study Before Jumping on the Tilray Bandwagon
Before you decide to buy or sell Tilray stock and move on to another cannabis play, at least take the time to consider three numbers from its quarterly report. I won’t say which way I’m leaning toward Tilray until the end -- the last time I wrote about TLRY in November, I cautioned investors to wait for a catalyst before buying -- but I can say that Tilray’s business isn’t nearly as bad as the headlines suggest.
Is It Time to Join the Party and Double Down on Canopy Growth Stock?
If anyone's wondering whether Constellation Brands is confident in its CGC stock holdings, here's your answer.
A Reverse Stock Split Was Too Little, Too Late to Save Aurora Cannabis Stock
With weak fundamentals, and the potential for shares to drop further, sell Aurora stock and consider better pot plays elsewhere.
Is Aurora Stock Worth Owning After Its Reverse Split?
The threat of dilution is real so prospective Aurora stockholders might consider other cannabis-sector investments instead.
Canopy Growth Stock has Upside Potential Emerging From This Covid-19 Hole
At one point pot stocks were all the rage. CGC stock is trying to make a comeback in spite of the drubbing it took during the Covid-19 crash.
Slimmed-Down Canopy Growth Stock Is a Cannabis Winner
Investors are punishing CGC stock for cost-cutting measures, but Canopy Growth now is more likely to survive Covid-19 than its bigger peers.
Why Investors Should Bet on Canopy Growth Now as it Readies for Later
CGC stock got a lift from production closures worldwide, so as its cost basis shrinks, Canopy Growth will eventually earn profits.
Best ETFs for 2020: The Alternative Harvest ETF Can Escape Virus Damage
The MJ ETF still has a shot at being one of the best ETFs in 2020, as marijuana becomes an essential business during the coronavirus crisis.
Canopy Growth Stock Is the Best Coronavirus Cannabis Play
Unlike its peers, Canopy Growth has strong fundamentals and an even stronger backer. CGC stock could be a buyout target later this year.
When the Smoke Clears, Canopy Growth Stock Will Be a Winner
Cannabis stocks are getting hammered. But the long-term opportunity remains, and CGC stock will remain the sector's leader.
